WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005066164) OPIOID RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/066164    International Application No.:    PCT/US2004/039766
Publication Date: 21.07.2005 International Filing Date: 15.12.2004
IPC:
C07D 213/78 (2006.01), C07D 213/82 (2006.01), C07D 401/04 (2006.01), C07D 409/14 (2006.01)
Applicants: ELI LILLY AND COMPANY [US/US]; Lilly Corporate Center, Indianapolis, Indiana 46285 (US) (For All Designated States Except US).
DE LA TORRE, Marta, Garcia [ES/ES]; (ES) (For US Only).
DIAZ BUEZO, Nuria [ES/ES]; (ES) (For US Only).
JADHAV, Prabhakar, Kondaji [US/US]; (US) (For US Only).
MITCH, Charles, Howard [US/US]; (US) (For US Only).
PEDREGAL-TERCERO, Concepcion [ES/ES]; (ES) (For US Only)
Inventors: DE LA TORRE, Marta, Garcia; (ES).
DIAZ BUEZO, Nuria; (ES).
JADHAV, Prabhakar, Kondaji; (US).
MITCH, Charles, Howard; (US).
PEDREGAL-TERCERO, Concepcion; (ES)
Priority Data:
03380303.2 22.12.2003 EP
60/539,748 28.01.2004 US
Title (EN) OPIOID RECEPTOR ANTAGONISTS
(FR) ANTAGONISTES DE RECEPTEUR D'OPIOIDES
Abstract: front page image
(EN)A compound of the formula (I); wherein the variables X1 to X10, R1 to R7 including R3', E, W, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.
(FR)L'invention porte sur un composé de la formule (I) ; les variables X1 à X10, R1 à R7 dont R3', E, W, v, y, z, A et B étant tels que décrits, ou sur un sel, un solvant, un énantiomère, un racémate, un diastéréomère ou des mélanges pharmaceutiquement acceptables de celui-ci, utiles dans le traitement, la prévention ou l'amélioration de l'obésité et des troubles associés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)